Anti-interleukin-4 monoclonal antibody 11B11

Drug Profile

Anti-interleukin-4 monoclonal antibody 11B11

Alternative Names: 11B11; Anti-interleukin-4 antibody 11B11

Latest Information Update: 19 Nov 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial sources; University of Tokyo
  • Class Monoclonal antibodies
  • Mechanism of Action Interleukin 4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Graft-versus-host disease; Systemic lupus erythematosus

Most Recent Events

  • 19 Nov 2003 Discontinued - Preclinical for Cancer in Japan (Intraperitoneal)
  • 19 Nov 2003 Discontinued - Preclinical for Graft-versus-host disease in Germany (unspecified route)
  • 19 Nov 2003 Discontinued - Preclinical for Graft-versus-host disease in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top